Although IL-10 expression was demonstrated to be upregulated in human breast cancer as well as in inflammatory mammary carcinomas in dogs [74,75], we did not find significant differences between IL-10 expression in healthy and neoplastic lesions, regardless of malignancy stage. This evidence concerns the gene IL10 and breast carcinoma.